Alternate Name	Item#	Length	Source of Standard	Column #
	2660	1000	NPCR	17765-18764

Description
Text area for manual documentation of information regarding the treatment of the tumor being reported with biological response modifiers or immunotherapy.

Rationale
Text documentation is an essential component of a complete electronic abstract and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.

The text field must contain a description that has been entered by the abstractor independently from the code(s). If cancer abstraction software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record and should not be generated electronically from coded values.

Instructions

• Prioritize entered information in the order of the fields listed below.
• Text automatically generated from coded data is not acceptable.
• NAACCR-approved abbreviations should be utilized (see Appendix G).
• Do not repeat information from other text fields.
• Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.
• If information is missing from the record, state that it is missing.
• Do not include irrelevant information.
• Do not include information that the registry is not authorized to collect.

Note: For abstracting software that allows unlimited text, NAACCR recommends that the software indicate to the abstractor the portion of the text that will be transmitted to the central registry.

Suggestions for text:

• Date treatment began
• Where treatment was given, e.g., at this facility, at another facility
• Type of BRM agent, e.g., Interferon, BCG
• BRM procedures, e.g., bone marrow transplant, stem cell transplant
• Other treatment information, e.g., treatment cycle incomplete; unknown if BRM was given

	Item name
	Date of Initial RX--SEER
	Date of 1st Crs RX--CoC
	RX Hosp--BRM
	RX Date Systemic
	RX Summ--Tranplnt/Endocr
	RX Summ--BRM
	RX Date--BRM
	RX Summ--Systemic/Sur Seq

Data Item(s) to be verified/validated using the text entered in this field
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:

Item name	Item number
Date Initial RX SEER	1260
Date 1Crs RX CoC	1270
RX Hosp--BRM	720
RX Date Systemic	3230
RX Summ--Tranplnt/Endocr	3250
RX Summ--BRM	1410
RX Date BRM	1240
RX Summ--Systemic/Sur Seq	1639